Gilead gets Sovaldi patent approval in India despite opposition

10-05-2016

Gilead gets Sovaldi patent approval in India despite opposition

Thirteen / Shutterstock.com

Gilead has been granted a patent for its hepatitis C drug Sovaldi (sofosbuvir) in India, despite concerns over the cost of the drug.


Gilead, Indian Patent Office, IPO, Patent, Sovaldi, sofosbuvir, MSF

LSIPR